Conotoxins: chemistry and biology

AH Jin, M Muttenthaler, S Dutertre, SWA Himaya… - Chemical …, 2019 - ACS Publications
The venom of the marine predatory cone snails (genus Conus) has evolved for prey capture
and defense, providing the basis for survival and rapid diversification of the now estimated …

[HTML][HTML] Peptide therapeutics from venom: Current status and potential

MW Pennington, A Czerwinski, RS Norton - Bioorganic & medicinal …, 2018 - Elsevier
Peptides are recognized as being highly selective, potent and relatively safe as potential
therapeutics. Peptides isolated from the venom of different animals satisfy most of these …

Natural products: an evolving role in future drug discovery

BB Mishra, VK Tiwari - European journal of medicinal chemistry, 2011 - Elsevier
The therapeutic areas of infectious diseases and oncology have benefited from abundant
scaffold diversity in natural products, able to interact with many specific targets within the cell …

On the utility of chemical strategies to improve peptide gut stability

T Kremsmayr, A Aljnabi… - Journal of medicinal …, 2022 - ACS Publications
Inherent susceptibility of peptides to enzymatic degradation in the gastrointestinal tract is a
key bottleneck in oral peptide drug development. Here, we present a systematic analysis of …

Natural products to drugs: natural product-derived compounds in clinical trials

MS Butler - Natural product reports, 2008 - pubs.rsc.org
Covering: 2005 to 2007 Natural product and natural product-derived compounds that are
being evaluated in clinical trials or are in registration (as at 31st December 2007) have been …

Conus venom peptide pharmacology

RJ Lewis, S Dutertre, I Vetter, MDJ Christie - Pharmacological reviews, 2012 - ASPET
Conopeptides are a diverse group of recently evolved venom peptides used for prey capture
and/or defense. Each species of cone snails produces in excess of 1000 conopeptides, with …

[HTML][HTML] Therapeutic potential of venom peptides

RJ Lewis, ML Garcia - Nature reviews drug discovery, 2003 - nature.com
Venomous animals have evolved a vast array of peptide toxins for prey capture and
defence. These peptides are directed against a wide variety of pharmacological targets …

Natural products to drugs: natural product derived compounds in clinical trials

MS Butler - Natural product reports, 2005 - pubs.rsc.org
Covering: 31st December 2004Natural product and natural product-derived compounds that
are being evaluated in clinical trials or in registration (current 31 December 2004) have …

Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations

AA Jensen, B Frølund, T Liljefors… - Journal of medicinal …, 2005 - ACS Publications
The neurotransmitter acetylcholine (ACh) exerts its effects on the central nervous system
(CNS) and peripheral nervous system (PNS) through two distinct types of receptors: the …

The engineering of an orally active conotoxin for the treatment of neuropathic pain

RJ Clark, J Jensen, ST Nevin, BP Callaghan… - Angewandte …, 2010 - infona.pl
Heilendes Gift: Peptide aus dem Gift der Kegelschnecke sind potenzielle Therapeutika zur
Behandlung von neuropathischem Schmerz. Ein Nachteil dieser Peptide ist ihre kurze …